Condition
Persistent Corneal Epithelial Defect clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Persistent Corneal Epithelial Defect clinical trials that are recruiting, at sites in 17 countries (most in United States (4), Germany (2), Italy (2)). 1 was first registered in the last 30 days. By phase: Phase 2 (3), Phase 3 (1), Phase 4 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 1New in 30 days
- 17Countries
Newest Persistent Corneal Epithelial Defect clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| TP-06 for Persistent Corneal Epithelial Defects: see if healing improves | Phase 2 | Scottsdale, Arizona and 13 other locations | Recruiting | Oct 21, 2026 |
| Topical insulin drops vs amniotic membrane graft for persistent corneal epithelial defects | Phase 4 | Rawalpindi, Punjab Province | Recruiting | May 1, 2026 |
| Efficacy and safety of cenegermin eye drops for persistent corneal epithelial defects | Phase 3 | Huntington Beach, California and 76 other locations | Recruiting | Apr 9, 2026 |
| Topical mesenchymal stem cell secretions for persistent corneal epithelial defects | Phase 2 | Chicago, Illinois | Recruiting | Apr 9, 2025 |
| Evaluating NEXAGON® for treating persistent corneal epithelial defects | Phase 2 | Dothan, Alabama and 27 other locations | Recruiting | Jul 28, 2023 |
All recruiting trials (5)
-
TP-06 for Persistent Corneal Epithelial Defects: see if healing improves
This study tests TP-06 2.0% versus a vehicle to see if it helps adult patients with persistent corneal epithelial defects heal better.
-
Topical insulin drops vs amniotic membrane graft for persistent corneal epithelial defects
We will test whether topical insulin eye drops or an amniotic membrane graft better helps heal persistent corneal epithelial defects that have not improved with standard treatment.
-
Efficacy and safety of cenegermin eye drops for persistent corneal epithelial defects
This study tests whether cenegermin eye drops can heal persistent corneal epithelial defects better than a vehicle in adults with PCED.
-
Topical mesenchymal stem cell secretions for persistent corneal epithelial defects
This trial will test whether eye drops made from bone-marrow mesenchymal stem cell secretions can help adults whose corneal epithelial defects have not healed with standard treatments.
-
Evaluating NEXAGON® for treating persistent corneal epithelial defects
This study is testing if NEXAGON® eye gel can help people with stubborn corneal problems that haven't improved with regular treatments.
Quick answers
How many Persistent Corneal Epithelial Defect clinical trials are recruiting right now?
5, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 17 countries. The most sites are in United States (4 trials), Germany (2 trials), Italy (2 trials), Spain (2 trials), Mexico (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3, Phase 3: 1, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.